Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 13.10x is 12% below its 5-year average of 14.95x, near the low end of its 5-year range (9.79x–22.44x).
8.95% below its 12-month average of 14.39x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 15.67x.
INTEREST COVERAGE RATIO
13.10x
INTEREST COVERAGE RATIO AVG TTM
14.39x
INTEREST COVERAGE RATIO AVG 3Y
13.62x
INTEREST COVERAGE RATIO AVG 5Y
14.95x
INTEREST COVERAGE RATIO AVG 10Y
14.99x
INTEREST COVERAGE RATIO AVG 15Y
96.17x
INTEREST COVERAGE RATIO AVG 20Y
118.94x
CURRENT VS TTM AVG
-8.95%
CURRENT VS 3Y AVG
-3.82%
CURRENT VS 5Y AVG
-12.38%
CURRENT VS 10Y AVG
-12.62%
CURRENT VS 15Y AVG
-86.38%
CURRENT VS 20Y AVG
-88.99%
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 409 covered companies
CURRENT VS SECTOR MEDIAN
+362.53%
vs the sector median at left
LeMaitre Vascular, Inc.
Market Cap
$1.82B
Interest Coverage Ratio
13.10x
TTM Avg
14.39x
3Y Avg
13.62x
5Y Avg
14.95x
Market Cap
$1.84B
Interest Coverage Ratio
1.57x
TTM Avg
2.14x
3Y Avg
5.67x
5Y Avg
7.21x
Market Cap
$1.78B
Interest Coverage Ratio
-206.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.86B
Interest Coverage Ratio
-596.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.88B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.88B
Interest Coverage Ratio
24.98x
TTM Avg
24.98x
3Y Avg
24.98x
5Y Avg
24.98x
Market Cap
$1.89B
Interest Coverage Ratio
-0.40x
TTM Avg
732.40x
3Y Avg
732.40x
5Y Avg
732.40x
Market Cap
$1.74B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | $1.82B | 13.10x | 14.39x | 13.62x | 14.95x |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 1.57x | 2.14x | 5.67x | 7.21x |
| Novocure Ltd (NVCR)vs › | $1.84B | N/A | 1.68x | 1.68x | 1.68x |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -206.92x | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.86B | -596.74x | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.88B | N/A | N/A | N/A | N/A |
| Novavax, Inc. (NVAX)vs › | $1.88B | 24.98x | 24.98x | 24.98x | 24.98x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -0.40x | 732.40x | 732.40x | 732.40x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | N/A | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.91B | N/A | 1.77x | 2.62x | 35.29x |
Interest Coverage
13.1x
Debt/Equity
0.45
Current Ratio
16.31
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 15.67x |
| 2026-03-31 | 13.67x |
| 2025-12-31 | 14.51x |
| 2025-09-30 | 15.66x |
| 2025-06-30 | 12.43x |
| 2025-03-31 | 9.79x |
| 2021-12-31 | 15.78x |
| 2021-09-30 | 14.61x |
| 2021-06-30 | 22.44x |
| 2021-03-31 | 13.77x |
| 2020-12-31 | 16.51x |
| 2020-09-30 | 15.06x |
| 2020-06-30 | 73.82x |
| 2018-12-31 | 3596.50x |
| 2017-12-31 | 301.05x |
| 2016-12-31 | 279.21x |
| 2014-09-30 | 308.67x |
| 2013-09-30 | 129.33x |
| 2013-06-30 | 180.88x |
| 2013-03-31 | 374.33x |
| 2011-12-31 | -416.00x |
| 2010-12-31 | -647.50x |
| 2010-03-31 | 317.50x |
| 2009-12-31 | 204.83x |
| 2009-09-30 | 323.25x |
| 2009-06-30 | 496.50x |
| 2009-03-31 | -71.18x |
| 2007-09-30 | -4.29x |
| 2007-06-30 | -1.30x |
